Established in 2020 Thursday, January 28, 2021


Drug eases recovery for those with severe alcohol withdrawal
Prazosin was originally developed to treat high blood pressure and is still used to treat prostate problems in men, among other conditions.



NEW HAVEN, CT.- A drug once used to treat high blood pressure can help alcoholics with withdrawal symptoms reduce or eliminate their drinking, Yale University researchers report Nov. 19 in the American Journal of Psychiatry.

In a double-blind study, researchers gave the drug prazosin or a placebo to 100 people entering outpatient treatment after being diagnosed with alcohol use disorder. All of the patients had experienced varying degrees of withdrawal symptoms prior to entering treatment.

According to the researchers, subjects with more severe symptoms — including shakes, heightened cravings and anxiety, and difficulty sleeping — who received prazosin significantly reduced the number of heavy drinking episodes and days they drank compared to those who received a placebo. The drug had little effect on those with few or no withdrawal symptoms.




“There has been no treatment readily available for people who experience severe withdrawal symptoms and these are the people at highest risk of relapse and are most likely to end up in hospital emergency rooms,” said corresponding author Rajita Sinha, the Foundations Fund Professor of Psychiatry, a professor of neuroscience, and director of the Yale Stress Center.

Prazosin was originally developed to treat high blood pressure and is still used to treat prostate problems in men, among other conditions. Previous studies conducted at Yale have shown that the drug works on stress centers in the brain and helps to improve working memory and curb anxiety and craving.

Sinha’s lab has shown that stress centers of the brain are severely disrupted early in recovery, especially for those with withdrawal symptoms and high cravings, but that the disruption decreases the longer the person maintains sobriety. Prazosin could help bridge that gap by moderating cravings and withdrawal symptoms earlier in recovery and increasing the chances that patients refrain from drinking, she said.

One drawback is that in its current form prazosin needs to be administered three times daily to be effective, Sinha noted.

The study was conducted at the Yale Stress Center and the Connecticut Mental Health Center’s Clinical Neuroscience Research Unit. It was supported by the National Institute of Alcoholism and Alcohol Abuse at the National Institutes of Health and the Connecticut State Department of Mental Health and Addiction Services.







Today's News

November 20, 2020

Vibrations of coronavirus proteins may play a role in infection

Fauci says Pfizer, Moderna Covid vaccine data is 'solid'

NASA-funded project uses images from space to study underwater volcanoes

Researchers discover secret social lives of giant poisonous rats

Clearing the course for glycans in development of flu drugs

Drug eases recovery for those with severe alcohol withdrawal

Can high-intensity exercise slow Parkinson's?

'Search of a lifetime' for supersymmetric particles at CERN

Experimenting in space to help prevent mudslides here on Earth

New effective and safe antifungal isolated from sea squirt microbiome

Tulane researcher launches study on how infants learn about their bodies

New technique seamlessly converts ammonia to green hydrogen

Regularly getting a good night's sleep lowers risks of heart failure

Arecibo telescope, star of the astronomy world, to be decommissioned

Field geology at Mars' equator points to ancient megaflood

UCLA receives $6.4 million to fund cannabis research

Vanderbilt researchers bring paradigm-shifting technology to endoscopic procedures

Does air pollution increase women's risk of dementia? Study finds high levels associated with brain shrinkage



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful